The fact that IL-24 can activate the expression of TNFα, as well as activate PKA and p38 MAPK in cancer cells, suggests that IL-24 might have the ability to activate SOCS through JAK/STAT-independent pathways, which can be relevant information in the context of cancer treatment and immune modulatory response. This evidence concerns the gene TNF and cancer.